2 posts • Page 1 of 1
Hi, David. Cyberknife is a type of very tightly-focused radiotherapy that is still being evaluated for prostate cancer as there is some evidence that it might increase the incidence of urinary side-effects such as urethritis, urinary incontinence, and urinary obstruction compared to conventional radiotherapy (44% versus 36% at 6 months following treatment). The theory is very appealing (less collateral damage because of more accurately targeted radiotherapy) but patients with more aggressive tumours might actually benefit from having a larger volume of tissue treated. For instance, the risk of having microscopic spread of prostate cancer in the pelvic lymph nodes in a man with a Gleason 7 tumour is 7% so having his pelvic lymph nodes (on either side of the prostate) treated with radiotherapy as well as his prostate is likely to benefit him.
Who is online
Users browsing this forum: No registered users and 2 guests